COMMUNIQUÉS West-GlobeNewswire

Catalyst Biosciences Announces Acceleration of Phase 1/2 Trial of CB 2679d/ISU304 in Individuals with Hemophilia B
18/12/2017
Korean Ministry of Food and Drug Safety Approves Omitting Cohort 4 and Dosing Cohort 5 with Six Daily Subcutaneous Doses of Next-Generation Coagulation Factor IX Current lower doses are predicted to achieve normal [...]
Arch Therapeutics Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
18/12/2017
FRAMINGHAM, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that the [...]
EDAP's Focal One® Robotic HIFU Treatments Performed at Acibadem Hospital, Istanbul, Turkey
18/12/2017
LYON, France, December 18, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the first HIFU treatments performed at Acibadem Hospital, Istanbul, Turkey, using the Company's [...]
ICU Medical, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
18/12/2017
SAN CLEMENTE, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]
REPEAT – Cannabis Wheaton Income Corp. Announces Sustainable Growth Strategic Capital Corp. as New Wheaton Streaming Partner
18/12/2017
VANCOUVER, British Columbia, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") is pleased to announce that it has entered into a [...]
Kura Oncology Added to Nasdaq Biotechnology Index
18/12/2017
SAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it has [...]
Innovation Pharmaceuticals Brilacidin Oral Mucositis Program Moving Forward Based Upon Positive Anchoring Phase 2 Results and Increased Brilacidin Franchise Value
18/12/2017
BEVERLY, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today is pleased to provide an update on the developmental plan for [...]
Intellia Therapeutics Names John Leonard, M.D., President and Chief Executive Officer
18/12/2017
Dr. Leonard has successfully led the development and regulatory approval of breakthrough biopharmaceuticals Company’s pipeline continues to advance toward clinical development CAMBRIDGE, Mass., Dec. 18, 2017 (GLOBE [...]
Major shareholder announcement
18/12/2017
Orphazyme A/S Company announcement No. 17/2017 Major shareholder announcement Copenhagen, December 18, 2017 – With reference to company announcement no. 5/2017 dated November 16, 2017 regarding the result of the Initial [...]
Sanofi and Alnylam submit Marketing Authorization Application to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis
18/12/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Alnylam submit Marketing Authorization Application to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis [...]
Sanofi et Alnylam présentent une demande d'autorisation de mise sur le marché à l'Agence européenne des médicaments pour le patisiran dans le traitement de l'amylose héréditaire à transthyrétine
18/12/2017
Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Alnylam présentent une demande d'autorisation de mise sur le marché à l'Agence européenne des médicaments pour le patisiran dans le traitement de [...]
Deciphera Pharmaceuticals, Inc. Added to Russell 2000® Index
18/12/2017
WALTHAM, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH ), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today [...]
Marrone Bio Innovations, Inc. Announces Comprehensive Financing and Debt Restructuring Transaction
18/12/2017
$30 Million Private Placement of Common Stock and Warrants Concurrent Conversion of $45 Million of Outstanding Debt into Equity Management to Host Corporate Update Conference Call to Discuss the Transaction on Monday, [...]
AxoGen Corporation Announces Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float
18/12/2017
ALACHUA, Fla., Dec. 18, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Dylan Harvey [...]
Urgent need for blood donors
18/12/2017
OTTAWA, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Canadian Blood Services is calling on eligible blood donors to help fill 35,000 appointments by Jan. 6 to ensure that Canadian patients continue to have access to the blood and [...]
BioDelivery Sciences Announces Notice of Allowance of Patent Strengthening Patent Protection on BELBUCA® to 2032
18/12/2017
RALEIGH, N.C., Dec. 18, 2017 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance of BDSI’s patent application [...]
Abattis Announces Expansion of Northern Vine Dealer’s License
18/12/2017
VANCOUVER, British Columbia, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (" Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce that Health Canada has approved an amendment to the dealer’s license [...]
Apeiron Announces Publication of Clinical Data with Anti-GD2 Antibody Demonstrating Efficacy in Relapsed & Refractory High-Risk Neuroblastoma
18/12/2017
VIENNA, Austria, Dec. 18, 2017 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, today announced the publication of a successful clinical study in high-risk neuroblastoma patients in [...]
RECORDATI: ACQUIRES TRANSIPEG®, TRANSIPEGLIB® AND COLOPEG® FOR THE FRENCH MARKET
18/12/2017
Milan, 18 December 2017 - Recordati announces the purchase of three Bayer Consumer Health brands for the French market: Transipeg®, TransipegLib® and Colopeg®. Transipeg® and TransipegLib® are macrogol based laxatives [...]

Pages